Wendy L. Dixon - Apr 6, 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
Director
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
Stock symbol
BDTX
Transactions as of
Apr 6, 2022
Transactions value $
$0
Form type
4
Date filed
4/7/2022, 04:16 PM
Previous filing
Apr 4, 2022
Next filing
Jun 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDTX Stock Option (Right to Buy) Award $0 +30K $0.00 30K Apr 6, 2022 Common Stock 30K $3.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments, with the first installment vesting on May 6, 2022, subject to the Reporting Person's continued service on each such vesting date.